Seoul : Samsung Electronics said on Tuesday it will invest 450 trillion won ($355 billion) in semiconductor and biopharmaceuticals for the next five years, as South Korea’s largest company seeks to further expand its business in future growth areas. The company said it will spend 360 trillion won, or 80 per cent of the investment, for research and development, and talent nurturing in South Korea, especially in advanced chipmaking. Samsung Electronics and Samsung Biologics will lead the investment in their respective business areas, it said. The planned investment is up 120 trillion won from the total 330 trillion won Samsung invested over the past five years, according to media agency reports.Samsung named semiconductors, biopharmaceuticals, artificial intelligence and next-generation communication technologies as the tech giant’s future growth drivers. Samsung said it will continue to aggressively invest in the semiconductor industry that has faced a chronic chip shortage over the past few years, and find new markets for further growth. In particular, Samsung said it will work to cement its leading position in the global memory chip market and try, at the same time, to improve its contract chip manufacturing business that lags far behind TSMC. Samsung also expected the investment to nurture a fabless ecosystem in South Korea, which in turn will drive growth in electric cars, smart factories, robotics and smart home appliances. The promised investment will be partly used for securing advanced chipmaking machines from, for example, ASML Holding N.V., the world’s leading photolithography equipment maker, and for creating 80,000 new jobs until 2026 in the chip and bio industries.
